Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# www.robotstxt.org # goo.gl/JzIqS User-agent: * Disallow: /harming/humans Disallow: /ignoring/human/orders Disallow: /harm/to/self Allow: |
Title | HEMACORD (HPC, Cord |
Description | Get the information that’s right for HEMACORD® (HPC, Cord Blood) For Physicians For Patients For Transplant Centers Contact We are pleased to announce the availability of HEMACORD® (HPC, Cord |
Keywords | N/A |
WebSite | hemacord.info |
Host IP | 20.120.80.220 |
Location | United States |
Site | Rank |
US$396,507
Last updated: 2023-05-13 07:59:49
hemacord.info has Semrush global rank of 26,693,877. hemacord.info has an estimated worth of US$ 396,507, based on its estimated Ads revenue. hemacord.info receives approximately 45,751 unique visitors each day. Its web server is located in United States, with IP address 20.120.80.220. According to SiteAdvisor, hemacord.info is safe to visit. |
Purchase/Sale Value | US$396,507 |
Daily Ads Revenue | US$367 |
Monthly Ads Revenue | US$10,981 |
Yearly Ads Revenue | US$131,763 |
Daily Unique Visitors | 3,051 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
hemacord.info. | A | 299 | IP: 20.120.80.220 |
hemacord.info. | NS | 86400 | NS Record: coby.ns.cloudflare.com. |
hemacord.info. | NS | 86400 | NS Record: ashley.ns.cloudflare.com. |
HEMACORD® (HPC, Cord Blood) For Physicians For Patients For Transplant Centers Contact We are pleased to announce the availability of HEMACORD® (HPC, Cord Blood), the first FDA approved allogeneic cord-blood derived hematopoietic stem cell therapy product There are thousands of HEMACORD® (HPC, Cord Blood) units available in inventory to provide the best possible matches. Get the information that’s right for you For Physicians For Patients For Transplant Centers Indications and Usage For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment. The risk benefit assessment for an individual patient depends on the patient characteristics, including disease, stage, risk factors, and specific manifestations of the disease, on |
HTTP/1.1 200 OK Server: nginx Date: Tue, 21 Dec 2021 00:38:33 GMT Content-Type: text/html; charset=utf-8 Content-Length: 13414 Last-Modified: Fri, 10 Dec 2021 18:02:30 GMT Connection: keep-alive Vary: Accept-Encoding ETag: "61b39636-3466" Expires: Wed, 22 Dec 2021 00:38:33 GMT Cache-Control: max-age=86400 Cache-Control: public X-UA-Compatible: IE=Edge,chrome=1 Accept-Ranges: bytes |
Domain Name: hemacord.info Registry Domain ID: b585eb1651c54448880f4135e0e49699-DONUTS Registrar WHOIS Server: http://whois.cloudflare.com Registrar URL: http://cloudflare.com Updated Date: 2021-12-09T21:04:51Z Creation Date: 2012-12-14T20:34:18Z Registry Expiry Date: 2022-12-14T20:34:18Z Registrar: Cloudflare, Inc Registrar IANA ID: 1910 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Registrant Organization: DATA REDACTED Registrant State/Province: New York Registrant Country: US Name Server: ashley.ns.cloudflare.com Name Server: coby.ns.cloudflare.com DNSSEC: unsigned >>> Last update of WHOIS database: 2021-12-24T19:01:56Z <<< |